|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 473/00 |
| (11) | Number of the document | 1660498 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04764776.3 |
| Date of filing the European patent application | 2004-09-02 | |
| (97) | Date of publication of the European application | 2006-05-31 |
| (45) | Date of publication and mention of the grant of the patent | 2007-08-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2004/009819 |
| Date | 2004-09-02 |
| (87) | Number | WO 2005/023811 |
| Date | 2005-03-17 |
| (30) | Number | Date | Country code |
| 0320738 | 2003-09-04 | GB |
| (72) |
LAWRENCE, Ronnie, Maxwell GlaxoSmithKline, GB
|
| (73) |
GLAXO GROUP LIMITED,
Glaxo Wellcome House, Berkeley Avenue,, Greenford, Middlesex UB6 0NN,
GB
|
| (54) | PROCESS FOR THE PREPARATION OF (1S,4R)-CIS-4-[2-AMINO-6-CHLORO-9H-PURIN-9-YL]-2-CYCLOPENTENE-1-METHANOL |
| PROCESS FOR THE PREPARATION OF (1S,4R)-CIS-4-[2-AMINO-6-CHLORO-9H-PURIN-9-YL]-2-CYCLOPENTENE-1-METHANOL |